Corilus N.V., a leader in medical software solutions for the primary care market in Belgium, has announced a significant strategic investment from PSG Equity. The investment aims to bolster Corilus’ market standing and expedite the company’s growth avenues. PSG Equity, known for partnering with software and technology-enabled services companies, will be collaborating with Rivean Capital, which acquired Corilus in 2020. The augmented partnership is aligned to drive both organic and inorganic growth, capitalizing on the accelerating digital transformation in the healthcare sector. With over 30,000 care providers utilizing its solutions, Corilus is positioned to expand its offerings and foothold across Europe. The transaction is set to complete by the end of the year, following regulatory approvals.

Healthcare Technology, Private Equity,Belgium, Europe